Yao Sumei, Ertay Ayse, Zhou Yilu, Yao Liudi, Hill Charlotte, Chen Jinliang, Guan Yangbo, Sun Hui, Ewing Rob M, Liu Yifei, Lv Xuedong, Wang Yihua
Department of Respiratory Medicine, The Second Affiliated Hospital of Nantong University, Nantong, China.
Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.
Front Oncol. 2021 May 31;11:654812. doi: 10.3389/fonc.2021.654812. eCollection 2021.
G protein-coupled receptor kinase 6 (GRK6) is expressed in various tissues and is involved in the development of several diseases including lung cancer. We previously reported that GRK6 is down-regulated in lung adenocarcinoma patients, which induces cell invasion and metastasis. However, further understanding of the role of GRK6 in lung adenocarcinoma is required. Here we explored the functional consequence of inhibition in lung epithelial cells. Analysis of TCGA data was coupled with RNA sequencing (RNA-seq) in alveolar epithelial type II (ATII) cells following depletion of with RNA interference (RNAi). Findings were validated in ATII cells followed by tissue microarray analysis. Pathway analysis suggested that one of the Hallmark pathways enriched upon GRK6 inhibition is 'Hallmark_Hypoxia' (FDR = 0.014). We demonstrated that depletion induces HIF1α (hypoxia-inducible factor 1 alpha) levels and activity in ATII cells. The findings were further confirmed in lung adenocarcinoma samples, in which GRK6 expression levels negatively and positively correlate with HIF1α expression ( = 0.015) and VHL expression ( < 0.0001), respectively. Mechanistically, we showed the impact of GRK6 on HIF activity could be achieved regulation of VHL levels. Taken together, targeting the HIF pathway may provide new strategies for therapy in GRK6-depleted lung adenocarcinoma patients.
G蛋白偶联受体激酶6(GRK6)在多种组织中表达,并参与包括肺癌在内的多种疾病的发生发展。我们之前报道过,GRK6在肺腺癌患者中表达下调,这会诱导细胞侵袭和转移。然而,仍需要进一步了解GRK6在肺腺癌中的作用。在此,我们探讨了在肺上皮细胞中抑制GRK6的功能后果。在通过RNA干扰(RNAi)耗尽GRK6后,对TCGA数据进行分析,并结合肺泡II型上皮细胞(ATII)的RNA测序(RNA-seq)。在ATII细胞中验证结果,随后进行组织微阵列分析。通路分析表明,GRK6抑制后富集的标志性通路之一是“标志性缺氧”(FDR = 0.014)。我们证明,GRK6耗尽会诱导ATII细胞中HIF1α(缺氧诱导因子1α)水平和活性升高。在肺腺癌样本中进一步证实了这一发现,其中GRK6表达水平分别与HIF1α表达呈负相关(P = 0.015),与VHL表达呈正相关(P < 0.0001)。从机制上讲,我们表明GRK6对HIF活性的影响可以通过调节VHL水平来实现。综上所述,靶向HIF通路可能为GRK6缺失的肺腺癌患者提供新的治疗策略。